Medical Aspects of Chemical and Biological Warfare
生物战
化学战
生物
毒理
微生物学
作者
Frederick R. Sidell,Ernest T. Takafuji,David R. Franz
标识
DOI:10.21236/ada398241
摘要
Abstract : This volume was prepared for military medical educational use. The focus of the information is to foster discussion that may form the basis of doctrine and policy. Until this decade, our military forces had not faced chemical and biological weapons since World War I, and the prevailing attitude has been of sight, out of mind. The Persian Gulf War changed all that. Just the threat that such weapons would be used was itself an effective weapon, as it required us to expend tremendous logistical resources to supply our troops in the desert. Now we know that we must master all relevant aspects of defense against chemical and biological warfare. The Biological Weapons Convention, ratified in 1975, did not slow the massive Soviet program, which continued until early 1992, nor did it prevent the buildup in Iraq between 1985 and 1990. At this time, experts are severely questioning whether verification of compliance with the treaty can be certain. Similar concerns delayed ratification of the Chemical Weapons Convention by the U.S. Senate; nevertheless, the senate ratified the treaty on 24 April 1997. A primary value of the Textbook of Military Medicine series is to preserve the lessons of past wars and, by so doing, demonstrate how current doctrine is built on knowledge that was gained at so high a cost. Medical officers should read this volume, Medical Aspects of Chemical and Biological Warfare, and learn its lessons well. Civilians expect that we in the military will know how to manage chemical and biological casualties. Indeed, if we do not, then who will? The nation expects us to be prepared to defend against all attacks and will be unforgiving of any incapacity on our part.